Dr.Peter Laussen on Empowering Care Teams for Enhanced Patient Outcomes
Testimonials
Related
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking
BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification […]
Boston Children’s enhances care with clinical intelligence platform
At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]